Tarsus Pharmaceuticals, Inc. (TARS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Tarsus Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -51.51x | -18.02x | -4.38x | -5.81x | -33.45x | -31.33x |
| P/B Ratio | 9.96x | 9.27x | 3.02x | 1.87x | 2.77x | 5.06x |
| P/S Ratio | 7.58x | 11.38x | 34.10x | 13.98x | 8.11x | 0.00x |
| Profitability | ||||||
| Gross Margin | 93.2% | 93.0% | 90.9% | 96.3% | 96.4% | 0.0% |
| Operating Margin | -15.7% | -65.9% | -820.5% | -242.9% | -21.3% | 0.0% |
| Net Margin | -14.7% | -63.2% | -778.9% | -240.5% | -24.2% | 0.0% |
| EBITDA Margin | -11.9% | -58.2% | -754.7% | -231.3% | -23.6% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 3.85x | 4.42x | 6.93x | 14.61x | 15.33x | 31.68x |
| Quick Ratio | 3.82x | 4.39x | 6.85x | 14.61x | 15.33x | 31.68x |
| Leverage | ||||||
| Debt/Equity | 0.27x | 0.32x | 0.15x | 0.10x | 0.01x | 0.01x |
YoY = year-over-year change. Source: FMP..